ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
2 announcements with these filters
Saroja Pharma Industries approved its draft Board Report, Management Discussion and Analysis Report, and the notice for its 8th Annual General Meeting.
Saroja Pharma announced the re-designation of Mr. Pulinattu Damodaran Nandakumar as Whole-time Director and the appointment of Mr. Niraj Variava as Internal Auditor.